To include your compound in the COVID-19 Resource Center, submit it here.
Ono launched Opdivo nivolumab in Japan to treat unresectable melanoma. The Japanese National Health Insurance (NHI) list
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury